Related Experiment Videos
Short hemodialysis: long-term mortality and morbidity
Artificial Organs
|June 1, 1986
Summary
Short hemodialysis (3 hours, 3 times weekly) is safe for patients, showing good survival rates and low hospitalization over 9 years. This treatment approach appears effective for chronic kidney disease management.
Area of Science:
- Nephrology
- Internal Medicine
- Renal Replacement Therapy
Background:
- Short hemodialysis (3-hour sessions, thrice weekly) was implemented in 1976.
- This approach aimed to provide individualized treatment schedules for patients with kidney failure.
Purpose of the Study:
- To evaluate the long-term safety and efficacy of short hemodialysis.
- To assess patient survival rates and hospitalization frequency in a cohort undergoing this treatment regimen.
Main Methods:
- Retrospective analysis of 259 patients treated between 1976 and 1985.
- Data collection on patient demographics, survival, causes of death, and hospitalization rates.
Main Results:
- Patient survival rates were 91% at 1 year, 76% at 5 years, and 60% at 10 years.
- Hospitalization rate averaged 7 days per patient per year, excluding initial therapy and access issues.
- No increased cardiovascular or infectious mortality was observed.
Conclusions:
- A 3-hour hemodialysis schedule, three times per week, can be safely administered for at least 9 years.
- Concerns regarding increased mortality and morbidity with short hemodialysis may stem from confounding factors, not the treatment itself.